Sandbox carlos: Difference between revisions
Jump to navigation
Jump to search
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
:*'''HIV'''<ref name=AIDSinfoNIH - Cystoisosporiasis>{{cite web | title = | :*'''HIV'''<ref name=AIDSinfoNIH - Cystoisosporiasis>{{cite web | title =AIDSinfo - Cystoisosporiasis| url =https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-oi-prevention-and-treatment-guidelines/352/isospora}}</ref> | ||
*In Patients with CD4 Count <200/mm3 (chronic treatment) | *In Patients with CD4 Count <200/mm3 (chronic treatment) | ||
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly | ::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly | ||
Revision as of 15:56, 16 July 2015
- Cytoisospora belli
Return to Top
- Immunocompetent
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO OR IV qid for 10 days
- patients with sulfa intolerance
- Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
- Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days
- HIV
- In Patients with CD4 Count <200/mm3 (chronic treatment)
- Prefered regimen: Trimethoprim-sulfamethoxazole 160 mg/800 mg PO 3 times weekly
- Alternative regimen (1): Trimethoprim-sulfamethoxazole 320 mg/1600 mg PO 3 times weekly
- Alternative regimen (2): Pyrimethamine 25 mg PO daily AND Leucovorin 5–10 mg PO daily
- Alternative regimen (3): Ciprofloxacin 500 mg PO 3 times weekly